These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 12429654)

  • 41. Tumor angiogenesis modulates leukocyte-vessel wall interactions in vivo by reducing endothelial adhesion molecule expression.
    Dirkx AE; Oude Egbrink MG; Kuijpers MJ; van der Niet ST; Heijnen VV; Bouma-ter Steege JC; Wagstaff J; Griffioen AW
    Cancer Res; 2003 May; 63(9):2322-9. PubMed ID: 12727857
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of vasculogenesis on solid tumor growth in a rat model.
    Muta M; Matsumoto G; Hiruma K; Saji S; Nakashima E; Toi M
    Oncol Rep; 2003; 10(5):1213-8. PubMed ID: 12883683
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MIC2 detection in tumors of bone and adjacent soft tissues.
    Devaney K; Abbondanzo SL; Shekitka KM; Wolov RB; Sweet DE
    Clin Orthop Relat Res; 1995 Jan; (310):176-87. PubMed ID: 7641436
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Direct comparison of umbilical cord blood versus bone marrow-derived endothelial precursor cells in mediating neovascularization in response to vascular ischemia.
    Finney MR; Greco NJ; Haynesworth SE; Martin JM; Hedrick DP; Swan JZ; Winter DG; Kadereit S; Joseph ME; Fu P; Pompili VJ; Laughlin MJ
    Biol Blood Marrow Transplant; 2006 May; 12(5):585-93. PubMed ID: 16635794
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-VEGFR2 and anti-IGF-1R-Adnectins inhibit Ewing's sarcoma A673-xenograft growth and normalize tumor vascular architecture.
    Ackermann M; Morse BA; Delventhal V; Carvajal IM; Konerding MA
    Angiogenesis; 2012 Dec; 15(4):685-95. PubMed ID: 22914877
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Induction of lasting complete regression of preformed distinct solid tumors by targeting the tumor vasculature using two new anti-endoglin monoclonal antibodies.
    Matsuno F; Haruta Y; Kondo M; Tsai H; Barcos M; Seon BK
    Clin Cancer Res; 1999 Feb; 5(2):371-82. PubMed ID: 10037187
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Utilization of bone marrow-derived endothelial cell precursors in spontaneous prostate tumors varies with tumor grade.
    Li H; Gerald WL; Benezra R
    Cancer Res; 2004 Sep; 64(17):6137-43. PubMed ID: 15342397
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bone marrow-derived lin(-)c-kit(+)Sca-1+ stem cells do not contribute to vasculogenesis in Lewis lung carcinoma.
    Shinde Patil VR; Friedrich EB; Wolley AE; Gerszten RE; Allport JR; Weissleder R
    Neoplasia; 2005 Mar; 7(3):234-40. PubMed ID: 15799823
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A fully human antimelanoma cellular adhesion molecule/MUC18 antibody inhibits spontaneous pulmonary metastasis of osteosarcoma cells in vivo.
    McGary EC; Heimberger A; Mills L; Weber K; Thomas GW; Shtivelband M; Lev DC; Bar-Eli M
    Clin Cancer Res; 2003 Dec; 9(17):6560-6. PubMed ID: 14695161
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increased expression of H/T-cadherin in tumor-penetrating blood vessels.
    Wyder L; Vitaliti A; Schneider H; Hebbard LW; Moritz DR; Wittmer M; Ajmo M; Klemenz R
    Cancer Res; 2000 Sep; 60(17):4682-8. PubMed ID: 10987267
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preclinical in vivo study of new insulin-like growth factor-I receptor--specific inhibitor in Ewing's sarcoma.
    Manara MC; Landuzzi L; Nanni P; Nicoletti G; Zambelli D; Lollini PL; Nanni C; Hofmann F; García-Echeverría C; Picci P; Scotlandi K
    Clin Cancer Res; 2007 Feb; 13(4):1322-30. PubMed ID: 17317844
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential expression of angiopoietin-1 and angiopoietin-2 may enhance recruitment of bone-marrow-derived endothelial precursor cells into brain tumors.
    Udani V; Santarelli J; Yung Y; Cheshier S; Andrews A; Kasad Z; Tse V
    Neurol Res; 2005 Dec; 27(8):801-6. PubMed ID: 16354539
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tumor Vessel Development and Expansion in Ewing's Sarcoma: A Review of the Vasculogenesis Process and Clinical Trials with Vascular-Targeting Agents.
    Stewart KS; Kleinerman ES
    Sarcoma; 2011; 2011():165837. PubMed ID: 21785569
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biologic characteristics of four Ewing's sarcomas.
    Workman ML; Soukup SW; Neely JE; Whitsett J; Ballard E; Lampkin B
    Cancer Genet Cytogenet; 1985 Feb; 15(3-4):215-25. PubMed ID: 2982475
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuronal Repressor REST Controls Ewing Sarcoma Growth and Metastasis by Affecting Vascular Pericyte Coverage and Vessel Perfusion.
    Zhou Z; Yang Y; Wang F; Kleinerman ES
    Cancers (Basel); 2020 May; 12(6):. PubMed ID: 32486064
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antiangiogenic therapy for primitive neuroectodermal tumor with thalidomide: A case report and review of literature.
    Li Q; Liu Y; Yu Y
    Medicine (Baltimore); 2017 Dec; 96(51):e9272. PubMed ID: 29390485
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preoperative therapy with pazopanib in high-risk soft tissue sarcoma: a phase II window-of-opportunity study by the German Interdisciplinary Sarcoma Group (GISG-04/NOPASS).
    Ronellenfitsch U; Dimitrakopoulou-Strauss A; Jakob J; Kasper B; Nowak K; Pilz LR; Attenberger U; Gaiser T; Egerer G; Fröhling S; Derigs HG; Schwarzbach M; Hohenberger P
    BMJ Open; 2016 Jan; 6(1):e009558. PubMed ID: 26739732
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Primary Multiple Pulmonary Primitive Neuroectodermal Tumor: Case Report and Literature Review.
    Dong M; Liu J; Song Z; Li X; Shi T; Wang D; Ren D; Chen J
    Medicine (Baltimore); 2015 Jul; 94(27):e1136. PubMed ID: 26166119
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Blocking SDF-1α/CXCR4 downregulates PDGF-B and inhibits bone marrow-derived pericyte differentiation and tumor vascular expansion in Ewing tumors.
    Hamdan R; Zhou Z; Kleinerman ES
    Mol Cancer Ther; 2014 Feb; 13(2):483-91. PubMed ID: 24282276
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stromal-cell-derived Factor 1-α Promotes Tumor Progression in Colorectal Cancer.
    Park SJ; Ahn TS; Cho SW; Kim CJ; Jung DJ; Son MW; Bae SH; Shin EJ; Lee MS; Kim CH; Baek MJ
    J Korean Soc Coloproctol; 2012 Feb; 28(1):27-34. PubMed ID: 22413079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.